Oxycodone vs Hydromorphone
Overview
Oxycodone and hydromorphone are both semi-synthetic opioids used for moderate-to-severe pain. Hydromorphone is ~4β5Γ more potent by oral route. Oxycodone has the advantage of both immediate-release and extended-release oral formulations and higher oral bioavailability.
Mechanism of Action
Both are full mu-opioid receptor agonists. Hydromorphone may also have delta-opioid receptor activity at high concentrations, which is pharmacologically relevant in some pain contexts.
Pharmacokinetics
Oxycodone: oral bioavailability 60β87%, CYP3A4 (β noroxycodone, less active) and CYP2D6 (β oxymorphone, active, minor). Half-life 4β6 h (IR). Hydromorphone: oral bioavailability 24%, half-life 2β3 h, H3G metabolite (neuroexcitatory at high doses).
Equianalgesic Conversion
Oral oxycodone 10 mg β oral hydromorphone 2β4 mg (approximately 4-5Γ potency difference PO).
Clinical Selection
Oxycodone IR/ER (OxyContin) are widely used for outpatient chronic pain. Hydromorphone PO is used when opioid rotation is needed for patients developing tolerance. Hydromorphone IV/SC is preferred for high-dose palliative care (high water solubility).
Key Takeaways
- Oxycodone: higher oral bioavailability, established ER formulation
- Hydromorphone: higher potency per mg, better SC/IV suitability
- Both avoid M6G problem of morphine in CKD
Verdict
Oxycodone is preferred for outpatient oral therapy due to higher bioavailability and established ER formulations. Hydromorphone is preferred for parenteral (IV/SC) palliative care dosing and opioid rotation in tolerant patients.